Genome-scale expression and transcription factor binding profiles reveal therapeutic targets in transgenic ERG myeloid leukemia. (2013)

First Author: Goldberg L
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood-2013-01-477133

PubMed Identifier: 23974202

Publication URI: http://europepmc.org/abstract/MED/23974202

Type: Journal Article/Review

Volume: 122

Parent Publication: Blood

Issue: 15

ISSN: 0006-4971